Better Crayons? How have these guys lost their wy? Danimer Scientific receives U.S. patent for renewable, biodegradable marking wax 08:03 DNMR Danimer Scientific announced that it received a U.S. Patent for a renewable, biodegradable marking wax that serves as an alternative to petrochemical-based paraffin wax. The patent was jointly awarded to Danimer Scientific and its partner in developing the material, Rob Falken, an environmentally focused material developer based in San Diego. The material can be used to make plant-based, compostable crayons that reliably break down in industrial composting facilities and home compost bins, unlike traditional crayons made with non-renewable paraffin wax that can take decades to decompose.
Iovance Biotherapeutics reports clinical data for TIL therapy LN-145 06:38 IOVA Iovance Biotherapeutics announced clinical data for its tumor infiltrating lymphocyte, or TIL, therapy LN-145 in patients with metastatic non-small cell lung cancer, or mNSCLC, who enrolled in Cohort 3B of the ongoing basket study IOV-COM-202. Cohort 3B enrolled patients that had progressed on prior immune checkpoint inhibitor, or ICI, therapy, including patients with oncogene-driven tumors who received prior tyrosine kinase inhibitor therapy. The overall response rate by investigator per RECIST 1.1 was 21.4% and the disease control rate was 64.3% following one-time treatment with LN-145 monotherapy, including two responders with PD-L1 negative tumors. Median duration of response was not reached at a median study follow up of 8.2 months. overall response rate might be a tad low!???
it's down pre-market, but i don't think everyone necessarily has been waiting on pins and needles for this set of results Iovance Biotherapeutics Inc 26.93 USD0.00 (0.00%)today Closed: Jun 29, 9:01 AM EDT · Pre-market 25.42 −1.51 (5.61%)
Verb Technology stock pops as new bull sees 20% upside Jun. 29, 2021 8:21 AM ETVerb Technology Company, Inc. (VERB) Verb Technology (NASDAQ:VERB) shares are up 25% pre-market to $1.66 after Ascendiant Capital analyst Edward Woo starts coverage with a Buy rating and Street-high $4 price target, a 20% upside to yesterday's close.
but the problem for those currently long the broader market is that Goldman's S&P 500 (SP500) (NYSEARCA:SPY) target is 4,300. That's fewer than 20 points from where the benchmark index closed on Friday. Inflation is a reason Citigroup equity strategists remain cautious about the next few months. "Inflation fears are well-founded as commodity costs are having an impact currently but labor expense could be the next issue to address," Citi's Tobias Levkovich writes in a note today. "There is significant anecdotal evidence about worker shortages and the need to boost pay, plus supply bottlenecks cannot be reversed overnight." "The Manufacturing PMI’s business price index is indicating further CPI increases and rising TIPs breakevens," he says. "NFIB surveys show quality of labor problems and they typically lead compensation direction, which will force companies to lift pricing, in our opinion."
But BofA Securities clients took the opportunity to sell into strength, continuing to take money from the high-value growth sectors. Retail and hedge funds clients sold last week, while institutional clients were small net buyers. Overall, clients were net sellers to the tune of -$1.5B in stocks.
Hey Van I have " beach brain " a condition which makes it hard to think straight. Did you see Purple Mattress? I was right to put the purple in Grandma's shorts! I need an idea! // Did you buy Chewie?
Thanks janes I'll look into it. Any broadening out to Taiwan (being discussed) will set this baby off. I had forgotten about them. Root Inc call volume above normal and directionally bullish 10:45 ROOT Bullish option flow…